-
Mashup Score: 0
Aims Patients with type 2 diabetes mellitus (T2D) and PAD have a markedly elevated risk of macrovascular events and death. The sodium glucose co-transporter 2 (SGLT2) inhibitor canagliflozin has wel…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 25Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes - 2 year(s) ago
The growth in prevalence of obesity, type 2 diabetes and nonalcoholic fatty liver disease (NAFLD) has become one of the most important global health challenges. The three chronic diseases are closely…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Aims Bempedoic acid inhibits ATP-citrate lyase (ACL), an enzyme in the cholesterol synthesis pathway. Mendelian randomization and genetic studies suggest decreased HMG-CoA reductase activity is asso…
Source: Diabetes, Obesity and MetabolismCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3
Aim To examine whether a low-carbohydrate, high-unsaturated/low-saturated fat diet (LC) improves glycaemic control and cardiovascular disease (CVD) risk factors in overweight and obese patients with…
Source: Diabetes, Obesity and MetabolismCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Associations of weight loss with obesity‐related comorbidities in a large integrated health system - 3 year(s) ago
Aims To determine the health outcomes associated with weight loss in individuals with obesity, and to better understand the relationship between disease burden (disease burden; ie, prior comorbiditi…
Source: Diabetes, Obesity and MetabolismCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 3
Aim To examine incident cardiovascular disease (CVD) and chronic kidney disease (CKD) diagnosis and associated healthcare resource utilization (HCRU) in a real-world population of patients with type…
Source: Diabetes, Obesity and MetabolismCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2A Global Country Level Analysis of The Relationship between Obesity and COVID‐19 Cases and Mortality - 3 year(s) ago
Background Obesity is being recognised as a risk factor for COVID-19 infection and severity. However, it is unclear if obesity is associated with COVID-19 at the ecological population-level, indepen…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 8Effectiveness of a ketogenic diet and virtual coaching intervention for patients with diabetes: a difference‐in‐differences analysis - 3 year(s) ago
Aims Nutrition interventions are key components of diabetes care. In light of increased disease prevalence among Veterans, the Veterans Health Administration (VA) partnered with Virta Health to test…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0SGLT2 inhibitors for type 2 diabetes mellitus in adults: an overview of forty‐six systematic reviews - 3 year(s) ago
Aims To summarize the evidence from systematic reviews (SRs) of randomized controlled trials (RCTs) evaluating the efficacy and safety of SGLT2 inhibitors (SGLT2i) versus placebo or active comparato…
Source: Diabetes, Obesity and MetabolismCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 12
Obesity is a major risk factor for development of severe COVID-19 infection and mortality. However, it is not known whether patients with obesity are at greater risk for development of post-acute seq…
Source: Diabetes, Obesity and MetabolismCategories: Healthcare Professionals, Latest HeadlinesTweet
Absolute risk reductions in CV events are large in people with peripheral artery disease with no increase risk of major adverse limb events. A high risk population who should be prioritised Pooled data from CANVAS & CREDENCE led by @ArnottClare: https://t.co/Tw1D3OT2Vz @cpcannon https://t.co/HyMDIDqv9e